A feasibility study of UFT/LV and irinotecan (TEGAFIRI) in advanced or metastatic colorectal cancer: Osaka Gastrointestinal Cancer Chemotherapy Study Group (OGSG) PROG 0304.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples